SARC 028: A phase II study of the anti-PD1 antibody pembrolizumab (P) in patients (Pts) with advanced sarcomas Meeting Abstract
| Authors: | Burgess, M. A.; Crowley, J.; Reinke, D. K.; Riedel, R. F.; George, S.; Movva, S.; Van Tine, B. A.; Davis, L. E.; Schuetze, S.; Hu, J.; Attia, S.; Priebat, D. A.; Reed, D. R.; D'Angelo, S. P.; Okuno, S. H.; Maki, R. G.; Patel, S.; Baker, L. H.; Tawbi, H. A. H. |
| Abstract Title: | SARC 028: A phase II study of the anti-PD1 antibody pembrolizumab (P) in patients (Pts) with advanced sarcomas |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036904654 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.tps10578 |
| Notes: | Meeting Abstract: TPS10578 -- Source: Wos |
